Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pérez MJR"'
Autor:
Monk BJ; GOG Foundation, Philadelphia; Florida Cancer Specialists and Research Institute, West Palm Beach, USA. Electronic address: bmonk@gog.org., Barretina-Ginesta MP; Medical Oncology Department, Institut Català d'Oncologia, Girona Biomedical Research Institute (IDIBGI-CERCA), Girona University, Girona; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain., Pothuri B; GOG Foundation, Philadelphia; Departments of Obstetrics/Gynecology and Medicine, Division of Gynecologic Oncology, Laura & Isaac Perlmutter Cancer Center, NYU Langone Health, New York, USA., Vergote I; University Hospitals Leuven, Leuven Cancer Institute, Leuven; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium., Graybill W; Division of Gynecologic Oncology, Medical University of South Carolina, Charleston, USA., Mirza MR; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Nordic Society of Gynaecologic Oncology (NSGO) - Clinical Trial Unit, Copenhagen, Denmark., McCormick CC; Legacy Medical Group Gynecologic Oncology, Portland, USA., Lorusso D; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of Sacred Heart, Rome; Multicenter Italian Trials in Ovarian Cancer (MITO), Rome, Italy., Moore RG; Division of Gynecologic Oncology, Wilmot Cancer Institute, Department of Obstetrics and Gynecology, University of Rochester, Rochester, USA., Freyer G; Centre Hospitalier Lyon-Sud Hospices Civils de Lyon, Oullins-Pierre-Bénite, France., O'Cearbhaill RE; GOG Foundation, Philadelphia; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York, USA., Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen; Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin; Berlin Institute of Health, Berlin, Germany., O'Malley DM; The Ohio State University and the James Comprehensive Cancer Center, Columbus, USA., Redondo A; Hospital Universitario La Paz - IdiPAZ, Madrid, Spain., Shahin MS; Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Asplundh Cancer Pavilion, Sidney Kimmel Medical College of Thomas Jefferson University, Willow Grove, USA., Vulsteke C; Integrated Cancer Center, AZ Maria Middelares, Ghent; Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium., Bradley WH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, USA., Haslund CA; Nordic Society of Gynaecologic Oncology (NSGO) - Clinical Trial Unit, Copenhagen, Denmark; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Chase DM; Department of Obstetrics and Gynecology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, USA., Pisano C; Multicenter Italian Trials in Ovarian Cancer (MITO), Rome, Italy; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Holman LL; Division of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, USA., Pérez MJR; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain; Hospital Reina Sofía, Córdoba, Spain., DiSilvestro P; Department of Obstetrics and Gynecology, Women and Infants Hospital/Alpert School of Medicine at Brown University, Providence, USA., Gaba L; Medical Oncology Department, Hospital Clinic de Barcelona, Translational Genomics and Targeted Therapies in Solid Tumors, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Herzog TJ; University of Cincinnati Cancer Center, Department of Obstetrics & Gynecology, College of Medicine, Cincinnati, USA., Bruchim I; Gynecologic Oncology Department, Hillel Yaffe Medical Center, Hadera; Technion Institute of Technology, Haifa; Israel and Israeli Society of Gynecologic Oncology (ISGO), Tel Aviv, Israel., Compton N; Compton Statistical Consulting Limited, Westerham, UK., Shtessel L; GSK, Durham., Malinowska IA; GSK, Waltham, USA., González-Martín A; Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain; Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov; Vol. 35 (11), pp. 981-992. Date of Electronic Publication: 2024 Sep 14.
Autor:
Vulsteke C; Integrated Cancer Center, AZ Maria Middelares, Ghent, and Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium. Electronic address: christof.vulsteke@mijnziekenhuis.be., Chambers SK; University of Arizona Cancer Center, Tucson, AZ, USA., Pérez MJR; Hospital Reina Sofía, Córdoba, and GEICO Grupo, Spain., Chan JK; California Pacific Medical Center, Palo Alto Medical Foundation, Sutter Cancer Research Consortium, San Francisco, CA, USA., Raaschou-Jensen N; Herlev Hospital Department of Oncology, Herlev, Denmark., Zhuo Y; Kadlec Hematology and Oncology Clinic, Richland, WA, USA., Lorusso D; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University of Sacred Heart, and MITO, Rome, Italy., Herzog TJ; University of Cincinnati Cancer Center; Department of Obstetrics & Gynecology, College of Medicine, Cincinnati, OH, USA., de la Motte Rouge T; Department of Oncology, Eugene Marquis Cancer Center, Rennes, France., Thomes Pepin JA; Department of Gynecologic Oncology, Minnesota Oncology, Maplewood, MN, USA., Braicu EI; Charité Universitätsmedizin and Arbeitsgemeinschaft Gynäkologische Onkologie (AGO), Berlin, Germany., Chen LM; University of California-San Francisco Health, University of California-San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Levy T; Department of Obstetrics and Gynecology, Wolfson Medical Center, Tel Aviv Faculty of Medicine, Tel Aviv University, Holon, Israel., Barter JF; Holy Cross Hospital and Maryland Oncology Hematology, Silver Spring, MD, USA., Pilar Barretina-Ginesta M; Medical Oncology Department, Institut Català d'Oncologia, Girona Biomedical Research Institute (IDIBGI-CERCA), Girona University and GEICO, Girona, Spain., Joosens E; Jessa Hospital, Hasselt, Belgium., York W; GSK, Philadelphia, PA, USA., Malinowska IA; GSK, Waltham, MA, USA., González-Martín A; Medical Oncology Department, Program in Solid Tumours, CIMA, Cancer Center Clínica Universidad de Navarra, Madrid, and Grupo Español de Investigación en Cancer ginecológicO (GEICO), Madrid, Spain., Monk BJ; HonorHealth Research Institute, University of Arizona College of Medicine, Phoenix, and Creighton University School of Medicine, Phoenix, AZ, USA.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 208, pp. 114157. Date of Electronic Publication: 2024 Jun 10.
Autor:
Callens C; Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France. celine.callens@curie.fr., Rodrigues M; Medical Oncology Department, Institut Curie and Paris Sciences Lettres Research University, Paris, France.; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Briaux A; Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Frouin E; Clinic Bioinformatics Unit, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Eeckhoutte A; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Pujade-Lauraine E; ARCAGY Research, Paris, France., Renault V; Clinic Bioinformatics Unit, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Stoppa-Lyonnet D; Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Bieche I; Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Bataillon G; Department of Pathology, University Cancer Institute of Toulouse-Oncopole, Toulouse, France., Karayan-Tapon L; Biology of Cancer laboratory, University Hospital of Poitiers, Poitiers, France., Rochelle T; Biology of Cancer laboratory, University Hospital of Poitiers, Poitiers, France., Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.; Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, and AGO, Berlin, Germany., Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, and MITO, Napoli, Italy., Pérez MJR; Hospital Reina Sofia, Cordoba, and GEICO Group, Córdoba, Spain., Grimm C; Division of General Gynecology and Gynecologic Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, and AGO Austria, Vienna, Austria., Nøttrup TJ; Department of Oncology, Copenhagen University Hospital-Rigshospitalet and NSGO, Copenhagen, Denmark., Colombo N; Dipartimento Medicina e Chirurgia, Università Milano-Bicocca, Istituto Europeo Oncologia, Milano, and MaNGO, Milano, Italy., Vergote I; University Hospital Leuven, Leuven Cancer Institute, and BGOG, Leuven, Belgium., Yonemori K; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, and GOTIC, Tokyo, Japan., Ray-Coquard I; Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon, and GINECO, Lyon, France., Stern MH; Genetics Laboratory, Department of Diagnostic and Theranostic Medicine, Institut Curie and Paris Sciences Lettres Research University, Paris, France.; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie and Paris Sciences Lettres Research University, Paris, France., Popova T; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.) Team, Institut Curie and Paris Sciences Lettres Research University, Paris, France.
Publikováno v:
Oncogene [Oncogene] 2023 Nov; Vol. 42 (48), pp. 3556-3563. Date of Electronic Publication: 2023 Nov 09.
Autor:
Poveda A; Initia Oncology, Valencia, Spain. Electronic address: apoveda@initiaoncologia.com., Lheureux S; Princess Margaret Hospital, Department of Medical Oncology, Toronto, ON, Canada., Colombo N; University of Milan-Bicocca and European Institute of Oncology IRCCS, Milan, Italy., Cibula D; General University Hospital in Prague, First Faculty of Medicine, Charles University, Prague, Czech Republic., Lindemann K; Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Weberpals J; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Bjurberg M; Skåne University Hospital, Lund University, Lund, Sweden., Oaknin A; Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Sikorska M; Olsztyn Provincial Specialist Hospital, Olsztyn, Poland., González-Martín A; Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Clinica Universidad de Navarra, Madrid, Spain., Madry R; Medical University Karol Marcinkowski, Poznań, Poland., Pérez MJR; Hospital Universitario Reina Sofía, Córdoba, Spain., Ledermann J; UCL Cancer Institute, University College London and UCL Hospitals, London, UK., Davidson R; AstraZeneca, Cambridge, UK., Blakeley C; AstraZeneca, Cambridge, UK., Bennett J; AstraZeneca, Cambridge, UK., Barnicle A; AstraZeneca, Cambridge, UK., Škof E; Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2022 Mar; Vol. 164 (3), pp. 498-504. Date of Electronic Publication: 2022 Jan 19.